close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis (switch to Discounted Cash Flow Analysis)
Dollar24Point07
Implied share price

Sell Overvalued by 68.4%

5% margin of safety What's this?

EV / EBITDA
Use Average
GENZ
Genzyme Corporation
AZN
AstraZeneca plc (ADR)
Change
AMGN
Amgen, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
SNY
Sanofi SA (ADR)
Change
7.16 23.69 6.09 12.08 4.86 5.14
All amounts in millions
from last financial year
         
Implied Share Price $24.07 $40.01 $101.91 $120.72 $56.27
Market Cap 18,291 173,797 128,695 105,678 100,826
Net Debt -371 8,200 47 7,450 7,330
Enterprise Value (EV) 18,961 49,995 128,742 113,128 57,252
Revenue 4,048 24,708 21,662 32,639 34,861
EBITDA 800 8,210 10,657 23,287 11,136
Percent 19.8 % 33.2 % 49.2 % 71.3 % 31.9 %
EBIT 332 5,929 8,530 22,189 7,186
Percent 8.2 % 24.0 % 39.4 % 68.0 % 20.6 %
Balance Sheet          
Total Assets 10,913 60,124 71,449 51,716 102,321
Total Liabilities 3,326 41,634 43,366 33,182 44,272
Shareholders Equity 7,586 18,490 28,083 18,534 58,049.0

Comments

No comments yet. Login to comment.